Exodus Point Capital Management, LP Biodesix Inc Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$1.21 - $1.71 $50,149 - $70,872
41,446 New
41,446 $63,000
Q3 2021

Nov 15, 2021
SELL
$6.6 - $12.78 $99,660 - $192,978
-15,100 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$12.14 - $20.35 $183,314 - $307,285
15,100 New
15,100 $199,000
Q1 2021

May 17, 2021
SELL
$16.87 - $31.21 $658,368 - $1.22 Million
-39,026 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$10.89 - $20.16 $424,993 - $786,764
39,026 New
39,026 $787,000

Others Institutions Holding BDSX

# of Institutions
58
Shares Held
62.3M
Call Options Held
2.6K
Put Options Held
10.1K
View Full List

About BIODESIX INC

BDSX Quotes by TradingView
  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $55.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email